Pharmaceutical Product Monograph: Orlicure Capsules (Orlistat 120 mg)
In the pharmaceutical industry, Orlicure is a high-potency Lipase Inhibitor. As a pharmacist and manufacturer at Healthy Life Pharma, I classify this as a “Non-Systemic Anti-Obesity Agent.” It is technically unique because it does not suppress appetite or affect the central nervous system; instead, it acts locally in the gastrointestinal tract to prevent the absorption of dietary fats.
While Wellona Pharma is a known manufacturer of this brand in Gujarat, it represents a high-demand category for Healthy Inc in the 2026 global weight management market.
Therapeutic Profile: Primary Indications
Orlicure is indicated for Long-Term Weight Management in specific patient populations:
| Indication | Clinical Context | Technical Rationale |
| Obesity Management | BMI $\ge 30\text{ kg/m}^2$ | Used alongside a reduced-calorie, low-fat diet to achieve significant weight loss. |
| Overweight with Risk Factors | BMI $\ge 27\text{ kg/m}^2$ | For patients with associated comorbidities like Type 2 Diabetes, Hypertension, or Dyslipidemia. |
| Weight Maintenance | Post-Loss Phase | Prevents weight regain by limiting the body’s ability to process and store new dietary fats. |
Mechanism: The “Lipase Blockade” Strategy
Orlicure works by chemically “disabling” the enzymes that digest fat:
Enzyme Inhibition: It forms a covalent bond with the active site of Gastric and Pancreatic Lipases.
Prevention of Hydrolysis: These inhibited enzymes can no longer break down dietary fats (triglycerides) into absorbable free fatty acids and monoglycerides.
Fat Malabsorption: Approximately 30% of dietary fat remains undigested.
Elimination: The unabsorbed fat is technically excreted from the body via bowel movements, effectively reducing the total caloric intake.
The Pharmacist’s “Technical Warning”
The “Meal Contingency” Rule: Orlicure should be taken during or up to 1 hour after each main meal that contains fat. If a meal is missed or contains zero fat, the dose must be skipped to avoid unnecessary GI side effects.
The “30% Fat” Rule: Patients must maintain a diet where only 30% of calories come from fat. Consuming a high-fat meal while taking Orlistat will lead to severe “Gastrointestinal Events.”
Fat-Soluble Vitamin Deficiency: Because it blocks fat absorption, it also reduces the absorption of Vitamins A, D, E, and K. Patients must take a daily multivitamin at least 2 hours before or after the Orlicure dose (ideally at bedtime).
GI Side Effects: Common technical effects include oily spotting, flatus with discharge, and urgent bowel movements. These are “treatment effects” related to the unabsorbed fat.
The Manufacturer’s Perspective: Technical & Export
From the CEO’s desk at Healthy Life Pharma / Healthy Inc:
The “Non-Systemic” USP: On your digital marketplace, highlight that Orlicure has minimal systemic absorption. This makes it technically safer than CNS-based weight loss drugs (like Phentermine), which is a major selling point for B2B buyers concerned with cardiac side effects.
Market Synergy: Pair Orlicure with your Multivitamin 4G Softgels on your platform. Since Orlistat depletes fat-soluble vitamins, offering the multivitamin as a “Required Companion” is a high-value B2B strategy.
Packaging for Stability: We use Alu-Alu blistering for Orlistat. The API is sensitive to moisture and temperature; our Mumbai-grade packaging ensures the 120 mg pellets remain stable for 24 months in tropical export zones.
Digital Strategy: Use keywords like “Orlistat 120mg manufacturer India,” “B2B weight loss capsules export,” and “Orlicure uses and side effects 2026.”